284 related articles for article (PubMed ID: 37450935)
81. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.
Criner GJ; Connett JE; Aaron SD; Albert RK; Bailey WC; Casaburi R; Cooper JA; Curtis JL; Dransfield MT; Han MK; Make B; Marchetti N; Martinez FJ; Niewoehner DE; Scanlon PD; Sciurba FC; Scharf SM; Sin DD; Voelker H; Washko GR; Woodruff PG; Lazarus SC; ;
N Engl J Med; 2014 Jun; 370(23):2201-10. PubMed ID: 24836125
[TBL] [Abstract][Full Text] [Related]
82. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
[TBL] [Abstract][Full Text] [Related]
83. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.
Wedzicha JA; Calverley PM; Seemungal TA; Hagan G; Ansari Z; Stockley RA;
Am J Respir Crit Care Med; 2008 Jan; 177(1):19-26. PubMed ID: 17916806
[TBL] [Abstract][Full Text] [Related]
84. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
Yang IA; Fong KM; Sim EH; Black PN; Lasserson TJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD002991. PubMed ID: 17443520
[TBL] [Abstract][Full Text] [Related]
85. Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial.
Uzun S; Djamin RS; Kluytmans J; Van't Veer NE; Ermens AA; Pelle AJ; Mulder P; van der Eerden MM; Aerts J
Trials; 2012 Jun; 13():82. PubMed ID: 22682323
[TBL] [Abstract][Full Text] [Related]
86. Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.
Devereux G; Cotton S; Nath M; McMeekin N; Campbell K; Chaudhuri R; Choudhury G; De Soyza A; Fielding S; Gompertz S; Haughney J; Lee AJ; MacLennan G; Morice A; Norrie J; Price D; Short P; Vestbo J; Walker P; Wedzicha J; Wilson A; Wu O; Lipworth BJ
JAMA; 2024 May; ():. PubMed ID: 38762800
[TBL] [Abstract][Full Text] [Related]
87. Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.
Wang C; Sun T; Huang Y; Humphries M; Bai L; Li L; Wang Q; Kho P; Firth R; D'Andrea P
Int J Chron Obstruct Pulmon Dis; 2015; 10():57-68. PubMed ID: 25609940
[TBL] [Abstract][Full Text] [Related]
88. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
89. A double-blind, randomised, placebo-controlled study of roxithromycin and doxycycline combination, roxithromycin alone, or matching placebo for 12 weeks in adults with frequent exacerbations of chronic obstructive pulmonary disease.
Shafuddin E; Mills GD; Holmes MD; Poole PJ; Mullins PR; Black PN
J Negat Results Biomed; 2015 Sep; 14():15. PubMed ID: 26346300
[TBL] [Abstract][Full Text] [Related]
90. Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial).
Urwyler P; Boesing M; Abig K; Cattaneo M; Dieterle T; Zeller A; Bachler H; Markun S; Senn O; Merlo C; Essig S; Ullmer E; Rutishauser J; Schuurmans MM; Leuppi JD
Trials; 2019 Dec; 20(1):727. PubMed ID: 31842993
[TBL] [Abstract][Full Text] [Related]
91. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.
Decramer M; Celli B; Kesten S; Lystig T; Mehra S; Tashkin DP;
Lancet; 2009 Oct; 374(9696):1171-8. PubMed ID: 19716598
[TBL] [Abstract][Full Text] [Related]
92. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy.
Han MK; Tayob N; Murray S; Dransfield MT; Washko G; Scanlon PD; Criner GJ; Casaburi R; Connett J; Lazarus SC; Albert R; Woodruff P; Martinez FJ
Am J Respir Crit Care Med; 2014 Jun; 189(12):1503-8. PubMed ID: 24779680
[TBL] [Abstract][Full Text] [Related]
93. Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial.
Choudhury AB; Dawson CM; Kilvington HE; Eldridge S; James WY; Wedzicha JA; Feder GS; Griffiths CJ
Respir Res; 2007 Dec; 8(1):93. PubMed ID: 18162137
[TBL] [Abstract][Full Text] [Related]
94. Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis.
Puhan MA; Bachmann LM; Kleijnen J; Ter Riet G; Kessels AG
BMC Med; 2009 Jan; 7():2. PubMed ID: 19144173
[TBL] [Abstract][Full Text] [Related]
95. The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
McDowell PJ; Diver S; Yang F; Borg C; Busby J; Brown V; Shrimanker R; Cox C; Brightling CE; Chaudhuri R; Pavord ID; Heaney LG;
Lancet Respir Med; 2021 Oct; 9(10):1174-1184. PubMed ID: 33971168
[TBL] [Abstract][Full Text] [Related]
96. Effect of doxycyline in chronic obstructive pulmonary disease - An exploratory study.
Singh B; Ghosh N; Saha D; Sarkar S; Bhattacharyya P; Chaudhury K
Pulm Pharmacol Ther; 2019 Oct; 58():101831. PubMed ID: 31349003
[TBL] [Abstract][Full Text] [Related]
97. Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial.
Brill SE; Law M; El-Emir E; Allinson JP; James P; Maddox V; Donaldson GC; McHugh TD; Cookson WO; Moffatt MF; Nazareth I; Hurst JR; Calverley PM; Sweeting MJ; Wedzicha JA
Thorax; 2015 Oct; 70(10):930-8. PubMed ID: 26179246
[TBL] [Abstract][Full Text] [Related]
98. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
Yun JH; Lamb A; Chase R; Singh D; Parker MM; Saferali A; Vestbo J; Tal-Singer R; Castaldi PJ; Silverman EK; Hersh CP;
J Allergy Clin Immunol; 2018 Jun; 141(6):2037-2047.e10. PubMed ID: 29709670
[TBL] [Abstract][Full Text] [Related]
99. Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease.
Shin SH; Park HY; Kang D; Cho J; Kwon SO; Park JH; Lee JS; Oh YM; Sin DD; Kim WJ; Lee SD;
Respir Res; 2018 Jul; 19(1):134. PubMed ID: 30001715
[TBL] [Abstract][Full Text] [Related]
100. Metoprolol for the Prevention of Acute Exacerbations of COPD.
Dransfield MT; Voelker H; Bhatt SP; Brenner K; Casaburi R; Come CE; Cooper JAD; Criner GJ; Curtis JL; Han MK; Hatipoğlu U; Helgeson ES; Jain VV; Kalhan R; Kaminsky D; Kaner R; Kunisaki KM; Lambert AA; Lammi MR; Lindberg S; Make BJ; Martinez FJ; McEvoy C; Panos RJ; Reed RM; Scanlon PD; Sciurba FC; Smith A; Sriram PS; Stringer WW; Weingarten JA; Wells JM; Westfall E; Lazarus SC; Connett JE;
N Engl J Med; 2019 Dec; 381(24):2304-2314. PubMed ID: 31633896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]